These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21956813)

  • 41. Effect of protein and calorie malnutrition on drug metabolism in rat - in vitro.
    Mao ZL; Tam YK; Coutts RT
    J Pharm Pharm Sci; 2006; 9(1):60-70. PubMed ID: 16849009
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Software-aided structural elucidation in drug discovery.
    Ahlqvist M; Leandersson C; Hayes MA; Zamora I; Thompson RA
    Rapid Commun Mass Spectrom; 2015 Nov; 29(21):2083-9. PubMed ID: 26443410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Influence of uremia on glucuronization of drugs in rat liver microsomes].
    Leber HW; Gleumes A; Schütterle G
    Verh Dtsch Ges Inn Med; 1973; 79():711-3. PubMed ID: 4789956
    [No Abstract]   [Full Text] [Related]  

  • 44. Ascorbic acid and liver microsomal drug metabolism.
    Zannoni VG
    Acta Vitaminol Enzymol; 1977; 31(1-5):17-29. PubMed ID: 580685
    [No Abstract]   [Full Text] [Related]  

  • 45. The effect of solvents on drug metabolism in vitro.
    Kawalek JC; Andrews AW
    Drug Metab Dispos; 1980; 8(6):380-4. PubMed ID: 6109604
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experimental design on single-time-point high-throughput microsomal stability assay.
    Di L; Kerns EH; Gao N; Li SQ; Huang Y; Bourassa JL; Huryn DM
    J Pharm Sci; 2004 Jun; 93(6):1537-44. PubMed ID: 15124211
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of intrinsic clearance for prediction of human hepatic clearance.
    Chao P; Uss AS; Cheng KC
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):189-98. PubMed ID: 20073997
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of pregnenolone-16 alpha-carbonitrile and other microsomal enzyme inducers on drug metabolism and some parameters of adjuvant induced disease in rats.
    Kourounakis P; Hadjipetrou-Kourounakis L
    Pharm Acta Helv; 1984; 59(12):348-52. PubMed ID: 6522414
    [No Abstract]   [Full Text] [Related]  

  • 49. Hepatic biotransformation of docetaxel (Taxotere) in vitro: involvement of the CYP3A subfamily in humans.
    Marre F; Sanderink GJ; de Sousa G; Gaillard C; Martinet M; Rahmani R
    Cancer Res; 1996 Mar; 56(6):1296-302. PubMed ID: 8640817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Voltammetric and electrogeneration approaches for the assessment of the oxidative drug metabolism.
    Rodríguez-Cid L; Sentellas S; Saurina J
    Anal Bioanal Chem; 2018 Mar; 410(8):2229-2239. PubMed ID: 29380015
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low-Turnover Drug Molecules: A Current Challenge for Drug Metabolism Scientists.
    Hutzler JM; Ring BJ; Anderson SR
    Drug Metab Dispos; 2015 Dec; 43(12):1917-28. PubMed ID: 26363026
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design.
    Di L; Keefer C; Scott DO; Strelevitz TJ; Chang G; Bi YA; Lai Y; Duckworth J; Fenner K; Troutman MD; Obach RS
    Eur J Med Chem; 2012 Nov; 57():441-8. PubMed ID: 22840492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Species differences in hepatic microsomal drug-metabolizing enzymes.
    Danek L; Nocoń H; Tarnawska A; Melzacka M
    Pol J Pharmacol Pharm; 1988; 40(4):351-6. PubMed ID: 3222176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms of inhibition of drug metabolic reactions.
    Gillette J; Sasame H; Stripp B
    Drug Metab Dispos; 1973; 1(1):164-75. PubMed ID: 4149379
    [No Abstract]   [Full Text] [Related]  

  • 55. Nuclear drug metabolism: its ontogeny in the rat and its presence in human fetal life.
    Romano M; Tursi F; Assael BM; Buscaglia M; Dell'Agnola CA; Salmona M
    Prog Clin Biol Res; 1983; 135():395-400. PubMed ID: 6665014
    [No Abstract]   [Full Text] [Related]  

  • 56. The metabolism of drugs in isolated rat hepatocytes. A comparison with in vivo drug metabolism and drug metabolism in subcellular liver fractions.
    Billings RE; McMahon RE; Ashmore J; Wagle SR
    Drug Metab Dispos; 1977; 5(6):518-26. PubMed ID: 21776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons.
    Brandon EF; Raap CD; Meijerman I; Beijnen JH; Schellens JH
    Toxicol Appl Pharmacol; 2003 Jun; 189(3):233-46. PubMed ID: 12791308
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retrospective assessment of rat liver microsomal stability at NCATS: data and QSAR models.
    Siramshetty VB; Shah P; Kerns E; Nguyen K; Yu KR; Kabir M; Williams J; Neyra J; Southall N; Nguyễn ÐT; Xu X
    Sci Rep; 2020 Nov; 10(1):20713. PubMed ID: 33244000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Species differences in pharmacokinetics.
    Parke DV
    Vet Res Commun; 1983 Dec; 7(1-4):285-300. PubMed ID: 6364551
    [No Abstract]   [Full Text] [Related]  

  • 60. Drug metabolism after repeated treatments with cytotoxic agents.
    Donelli MG; Garattini S
    Eur J Cancer (1965); 1971 Aug; 7(4):361-4. PubMed ID: 5570713
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.